The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.

Pihlmann Kristensen, Maria; Korsgaard, Ulrik; Timm, Signe; Hansen, Torben Frøstrup; Zlobec, Inti; Hager, Henrik; Kjær-Frifeldt, Sanne (2024). The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program. Human pathology, 146, pp. 15-22. Elsevier 10.1016/j.humpath.2024.02.010

Preview

Text 1-s2.0-S0046817724000339-main.pdf - Accepted Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview

Tumor budding as a prognostic marker in colorectal cancer has not previously been investigated in a cohort of screened stage II colon cancer patients. We assess the prognostic significance of tumor budding in a thoroughly characterized stage II colon cancer population comprising surgically resected patients in the Region of Southern Denmark from 2014 to 2016. Tumors were re-staged according to the 8th edition of UICC TNM Classification, undergoing detailed histopathological evaluation and tumor budding assessment following guidelines from the International Tumor Budding Consensus Conference. Prognostic evaluation utilized Kaplan-Meier curves, log-rank tests, and Cox proportional hazard models for time to recurrence (TTR), recurrence-free survival (RFS), and overall survival (OS). Out of 497 patients, 20% were diagnosed through the national colorectal cancer screening program. High-grade tumor budding (Bd3) was found in 19%, and tumor budding was associated with glandular subtype, perineural invasion, mismatch repair proficient tumors, and tumor recurrence (p < 0.001, p < 0.001, p = 0.045 and p = 0.007 respectively). In multivariable Cox regression, high-grade tumor budding (Bd3) was a significant prognostic factor for TTR compared to low-grade (Bd3 HR 2.617; p = 0.007). An association between tumor budding groups and RFS was observed, and the difference was significant in univariable analysis for high-grade compared to low-grade tumor budding (Bd3 HR 1.461; p = 0.041). No significant differences were observed between tumor budding groups and OS. High-grade tumor budding is a predictor of recurrence in a screened population of patients with stage II colon cancer and should be considered a high-risk factor in a shared decision-making process when stratifying patients to adjuvant chemotherapy.

Interest & Impact

Downloads

93 since deposited on 04 Mar 2024
93 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item